These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1986025)

  • 1. Clinical review 17: Immunotherapy of type I diabetes mellitus.
    Marks JB; Skyler JS
    J Clin Endocrinol Metab; 1991 Jan; 72(1):3-9. PubMed ID: 1986025
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy in pre-type 1 diabetes mellitus.
    Bach JF; Dupré J; Eisenbarth GS; Harrison LC; Maclaren NK; Nerup J; Pozzilli P
    Diabetologia; 1990 Dec; 33(12):741. PubMed ID: 2073989
    [No Abstract]   [Full Text] [Related]  

  • 3. Early intervention in insulin-dependent diabetes mellitus.
    Cahill GF
    Curr Probl Clin Biochem; 1983; 12():108-18. PubMed ID: 6418442
    [No Abstract]   [Full Text] [Related]  

  • 4. Trials of immunotherapy to preserve beta-cell function of prediabetic and new-onset patient trials.
    Eisenbarth GS
    Curr Diab Rep; 2004 Apr; 4(2):85-6. PubMed ID: 15035966
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune intervention with anti-CD3 in diabetes.
    Harlan DM; von Herrath M
    Nat Med; 2005 Jul; 11(7):716-8. PubMed ID: 16015359
    [No Abstract]   [Full Text] [Related]  

  • 6. Nicotinamide: potential for the prevention of type 1 diabetes?
    Gale EA
    Horm Metab Res; 1996 Jul; 28(7):361-4. PubMed ID: 8858387
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunology of type-1 diabetes. The initial stages in a causal therapy].
    Scherbaum WA; Hedderich U; Pfeiffer EF
    Dtsch Med Wochenschr; 1986 Apr; 111(15):593-6. PubMed ID: 3514198
    [No Abstract]   [Full Text] [Related]  

  • 8. New developments in non-specific and semi-specific immunosuppression in type I diabetes.
    Leslie RD; Carotenuto P; Pozzilli P
    Diabetes Metab Rev; 1993 Dec; 9(4):257-67. PubMed ID: 7924823
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical aspects of the immunopathogenesis of type I diabetes mellitus].
    Scherbaum WA
    Internist (Berl); 1987 Apr; 28(4):228-35. PubMed ID: 3298122
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-CD4 antibodies in diabetes.
    Shizuru JA; Fathman CG
    Immunol Ser; 1993; 59():237-52. PubMed ID: 8096401
    [No Abstract]   [Full Text] [Related]  

  • 11. [Type I diabetes mellitus: immunopathogenesis and chances of primary immunotherapy].
    Ziegler AG; Standl E
    Med Klin (Munich); 1987 Oct; 82(22):796-800. PubMed ID: 3316970
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of insulin-dependent diabetes mellitus before the onset of clinical symptoms.
    Riley WJ; Winter WE; Maclaren NK
    J Pediatr; 1988 Feb; 112(2):314-6. PubMed ID: 3276866
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological disorder in diabetes mellitus].
    Takeuchi K; Jodo S; Koike T
    Nihon Rinsho; 1997 Oct; 55 Suppl():700-4. PubMed ID: 9392184
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrophages in islet destruction in autoimmune diabetes mellitus.
    Burkart V; Kolb H
    Immunobiology; 1996 Oct; 195(4-5):601-13. PubMed ID: 8933160
    [No Abstract]   [Full Text] [Related]  

  • 15. [Does the current knowledge on the pathogenesis of type 1 diabetes justify immunotherapeutic intervention?].
    Pozzilli P; Signore A; Andreani D
    Recenti Prog Med; 1986 May; 77(5):245-8. PubMed ID: 3526461
    [No Abstract]   [Full Text] [Related]  

  • 16. Type I diabetes mellitus: a chronic autoimmune disease?
    Rabinowe SL; Eisenbarth GS
    Pediatr Clin North Am; 1984 Jun; 31(3):531-43. PubMed ID: 6203091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological and ethical consiluations on trials with immunotherapy in pre-type 1 (insulin-dependent) diabetes mellitus.
    Dahlqvist G
    Diabetologia; 1991 Jul; 34(7):536. PubMed ID: 1916062
    [No Abstract]   [Full Text] [Related]  

  • 18. Type 1 diabetes: how to resist a fatal attraction.
    Roep BO
    Neth J Med; 2002 Aug; 60(7):296-7. PubMed ID: 12430578
    [No Abstract]   [Full Text] [Related]  

  • 19. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus.
    Muir A; Schatz DA; Maclaren NK
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):199-219. PubMed ID: 1612064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of self-tolerance is a feasible approach to control ongoing beta-cell specific autoreactivity: its relevance for treatment in established diabetes and islet transplantation.
    Chatenoud L
    Diabetologia; 2001 May; 44(5):521-36. PubMed ID: 11380070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.